News

PharmaLab returned to Düsseldorf, on 20th and 21st November for its sixth suc­ces­sive year cov­er­ing var­i­ous topics in eight inter­est­ing con­fer­ences and lec­tures on ana­lyt­ics, bio­an­a­lyt­ics, micro­bi­ol­ogy and R&D. It pro­vided a broad overview of cur­rent inno­va­tions with a focus on what’s nec­es­sary to sup­port bio­phar­ma­ceu­ti­cal prod­ucts towards approval and beyond. Approximately 400 vis­i­tors used the con­fer­ence as an ideal forum for shar­ing best prac­tices and learn­ing on how indus­try is apply­ing novel approaches to prod­uct devel­op­ment, man­u­fac­tur­ing, and reg­u­la­tory com­pli­ance with a focus on long term suc­cess. With a com­bi­na­tion of reowned speak­ers, dynamic ses­sions, panel dis­cus­sions and prac­ti­cal learn­ing, vis­it­ing the exhi­bi­tion area was an essen­tial part of both days.

35 sup­pli­ers includ­ing GBO made it simple for vis­i­tors to see and source the latest prod­uct advances/technologies in the field.

GBO proudly pre­sented the CytoInsepct™, a test kit used for the detec­tion and iden­ti­fi­ca­tion of mycoplasma that has suc­cess­fully applied as a batch release test in the man­u­fac­ture of bio­phar­ma­ceu­ti­cal prod­ucts by sev­eral glob­ally acting com­pa­nies.

Photo: Rizwan Chaudhrey, European Pharmaceutical Review